Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Conditions
Non-Muscle Invasive Bladder Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham - The Kirklin Clinic, Birmingham, Alabama, United States
University of Southern California, Los Angeles, California, United States
Urology Associates of Denver, Lone Tree, Colorado, United States
Urological Research Network, Hialeah, Florida, United States
Advanced Urology Institute, Largo, Florida, United States
Advent Health Orlando, Orlando, Florida, United States
Advanced Urology Institute 1, Oxford, Florida, United States
H Lee Moffitt Cancer Center, Tampa, Florida, United States
Northwestern University, Chicago, Illinois, United States
Associated Urological Specialists, Chicago Ridge, Illinois, United States
Urology of Indiana, Greenwood, Indiana, United States
Urologic Specialists of Northwest Indiana, Merrillville, Indiana, United States
University of Kentucky, Lexington, Kentucky, United States
Southern Urology LLC, Lafayette, Louisiana, United States
Greater Boston Urology, Plymouth, Massachusetts, United States
Specialty Clinical Research of St Louis, St Louis, Missouri, United States
Hackensack University Medical Center Urology, Hackensack, New Jersey, United States
Associated Medical Professionals, Syracuse, New York, United States
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States
Central Ohio Urology Group, Gahanna, Ohio, United States
Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
Low Country Urology Clinics, North Charleston, South Carolina, United States
Urology Associates, Nashville, Tennessee, United States
Urology Austin, Austin, Texas, United States
Urology San Antonio Research, San Antonio, Texas, United States
Vancouver Prostate Centre Diamond Health Care Centre, Vancouver, British Columbia, Canada
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada
St Josephs Healthcare Hamilton, Hamilton, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Universitatsklinikum Carl Gustav Carus Dresden, Dresden, Germany
Urologicum Duisburg, Duisburg, Germany
Universitatsklinikum Frankfurt, Frankfurt am Main, Germany
Marien hospital Herne, Herne, Germany
Urologie Neandertal Praxis Mettmann, Mettmann, Germany
Universitatsklinikum Munster, Münster, Germany
Universitaetsklinikum Ulm, Ulm, Germany
Rambam Medical Center, Haifa, Israel
Carmel Medical Center, Haifa, Israel
Rabin Medical Center, Petah Tikva, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
Yamanashi Prefectural Central Hospital, Kofu, Japan
Osaka General Medical Center, Osaka, Japan
Toyama University Hospital, Toyama, Japan
Radboud Umcn, Nijmegen, Netherlands
UMC Utrecht, Utrecht, Netherlands
National Cancer Center, Goyang-si, South Korea
Chonnam National University Hospital, Gwangju, South Korea
Seoul National University Hospital, Seoul, South Korea
Severance Hospital Yonsei University Health System, Seoul, South Korea
The Catholic University of Korea Seoul St Marys Hospital, Seoul, South Korea
Fund. Puigvert, Barcelona, Spain
Hosp Univ Vall D Hebron, Barcelona, Spain
Hosp Clinic de Barcelona, Barcelona, Spain
Hosp Reina Sofia, Córdoba, Spain
Hosp Univ Fund Jimenez Diaz, Madrid, Spain
Hosp. Univ. 12 de Octubre, Madrid, Spain
Hosp. Univ. La Paz, Madrid, Spain
Instituto Valenciano de Oncologia, Valencia, Spain
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC